Sign In

CPG Infobase: Clinical Practice Guidelines

0 comment(s)

Record Id:
13945
Title:
Optimal use recommendations for second- and third-line therapy for patients with type 2 diabetes
Fulltext:
View PDF
Publication/Review date:
2013-July 
Producers:
Canadian Agency for Drugs and Technologies in Health

Bibliographic Source

Place of Publication:
Ottawa (ON)
Publisher(s):
Canadian Agency for Drugs and Technologies in Health
Date Accessed:
2013-07-23
Pages/Size:
23  Page(s)
References:
13

Subject Information

Specialties:
Endocrinology and metabolism, Family practice,
Conditions:
Diabetes;
Domains:
Treatment
Target Populations:
Adult
Target Gender:
Unknown
MeSH:
Hypoglycemic Agents; Drug Therapy; Diabetes Mellitus, Type 2; Sulfonylurea Compounds; Insulin;

Copyright:

The copyright of this guideline and its companion documents belongs to: Canadian Agency for Drugs and Technologies in Health

Disclaimer:
All content is provided for information and education and not as a substitute for the advice of a physician. Joule assumes no responsibility or liability arising from any error or omission or from the use of any information contained herein.

Discuss this CPG

Share your ideas and expertise on this topic.

​​​